Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: David Okrongly to Opko


Opko Health announced this week that it has appointed David Okrongly president of its diagnostics business unit.

Okrongly was previously chief operating officer of Exosome Diagnostics. Before that he was president and CEO of Quanterix as well as senior vice president of molecular diagnostics at Bayer Diagnostics.